Stryker vs. Zimmer Biomet vs. J&J in Q3: How 3 orthopedic companies compare

Stryker, Johnson & Johnson and Zimmer Biomet posted their third-quarter financial results for 2024 and data on their spine orthopedic sales.

Advertisement

Here is how they compare:

Stryker

Total sales: $5.5 billion (+11.9%)

Orthopedics: $2.3 billion (10.7%)

Hips: $420 million (+15.9%)

Knees: $570 million (+10.6%)

Spine: $304 million (+4.6%)

Net gain: $834 million 

Zimmer Biomet

Total sales: $1.8 billion (+4%)

Hips: $481.5 million (+3.5%)

Knees: $745.1 million (+5.5%)

Sports medicine, extremities, trauma, craniomaxillofacial and thoracic: $464.2 million (+7.3%)

Net earnings: $249.1 million

Johnson & Johnson

Total sales: $22.5 billion (+5.2%)

Orthopedic: $2.2 billion (+1.2%)

Spine, sports and other: $696 million (-1.9%)

Hips: $381 million (+1.7%)

Knees: $352 million (+4%)

Net earnings: $2.7 billion

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.